Best Practices, LLC Releases Study on Digital Trends Driving Biopharma Launch Success
CHAPEL HILL, N.C., Oct. 13, 2025/ -- Best Practices, LLC has released a groundbreaking benchmarking study, "Digital Trends in Biopharma Launch Strategy and Investment," highlighting how digital transformation is redefining launch excellence across the biopharma industry.
Recent biopharma landscape has accelerated the adoption of digital technologies, pushing companies to integrate complete digital strategies into their traditional launch models. This research examines the most impactful digital activities, investment patterns, and success drivers shaping next-generation product launches.
According to the study, 73% of companies now embed digital specialists into launch teams, and more than half align digital goals directly with performance scorecards—signaling a strategic shift from experimentation to integration.
Digital is no longer a side strategy—it’s the foundation of how successful launches are planned, executed, and optimized. This research provides an actionable roadmap for companies looking to elevate their digital maturity and performance impact.
Key Topics Explored in the Report
- High-value digital activities and their acceleration across launch stages
- The impact of digital tools on medical, marketing, and sales outcomes
- Investment trends and the most effective performance metrics
- Insights from 12 biopharma leaders representing global organizations
For a deeper dive, download the complimentary report summary here: https://www.best-in-class.com/rw504.htm
Pressed for time? Watch the short video summary below to uncover the key findings and recommendations from the study: